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Parallel molecular evolution and adaptation are important phenomena commonly observed in
viruses. Here, we exploit parallel molecular evolution to understand virulence evolution in
avian influenza viruses (AIV). Highly-pathogenic AIVs evolve independently from low-
pathogenic ancestors via acquisition of polybasic cleavage sites. Why some AIV lineages but
not others evolve in this way is unknown. We hypothesise that the parallel emergence of
highly-pathogenic AIV may be facilitated by permissive or compensatory mutations occurring
across the viral genome. We combine phylogenetic, statistical and structural approaches to
discover parallel mutations in AIV genomes associated with the highly-pathogenic pheno-
type. Parallel mutations were screened using a statistical test of mutation-phenotype asso-
ciation and further evaluated in the contexts of positive selection and protein structure. Our
resulting mutational panel may help to reveal new links between virulence evolution and
other traits, and raises the possibility of predicting aspects of AIV evolution.
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Avian influenza A viruses (AIVs) infect bird populationsworldwide1. While most AIVs cause only a mild-to-asymptomatic infection, highly pathogenic (HP) avian
influenza, restricted to the H5 and H7 AIV subtypes, causes
extremely high mortality (up to 100%) in domestic bird popu-
lations1. Both low-pathogenic (LP) and HP viruses can
cause severe disease in humans following avian-to-human
transmission2,3. For example, the emergence of H7N9 AIV in
China caused >1500 infections and 615 human deaths between
2013 and early 2018 4. Low virulence AIVs have evolved into HP
strains on multiple occasions, resulting in geographically- and
temporally distinct outbreaks that cause substantial economic
losses to the poultry industry, and pose a risk of avian-to-human
spread5,6. It is therefore important to understand the mechanisms
driving the evolution of virulence in AIVs.
Virulence in influenza A viruses is, in general, a complex trait
that involves interactions among multiple viral proteins7–9.
However, the AIV HP phenotype is an unusually simple and well-
characterised molecular marker of virulence, and is therefore an
attractive system in which to study virulence evolution10. The HP
phenotype is conferred by a polybasic cleavage site (pCS) within
the viral haemagglutinin (HA) protein. The HA cleavage site is
located in the C-terminal domain of HA (Arg-343 in H1 num-
bering) and is highly conserved among all influenza A viruses,
including AIVs11. The insertion of one or more basic amino acids
at this site creates a pCS, which renders the HA protein a target
for broadly expressed host proteases, facilitating systemic virus
spread within avian hosts12. These insertions, and the subsequent
emergence of a pCS, have occurred several times during the
evolutionary history of AIVs: 25 different pCS sequences
have been described for HP H5NX viruses since 1961, and 24 pCS
have been described for HP H7NX viruses since 1963 11. How-
ever, the evolutionary pathways that lead to the independent,
parallel evolution of a pCS, and thus the HP phenotype, are not
well understood.
Parallel evolution describes repeated evolutionary changes
leading to the same phenotype or genotype in independent
populations, and can result from adaptation by natural selection
to similar selective pressures or ecological niches13,14. We use the
term ‘parallel molecular evolution’ to refer to the convergent or
parallel molecular genetic changes that lead to the emergence of
same phenotype15. RNA viruses exhibit high rates of mutation
(i.e. the rate at which errors are made during the virus genome
replication), large population sizes, high replication rates, con-
sistently varying environments, and strong selective pressures.
These factors, combined with small genome sizes, may restrict the
number of mutational pathways that can lead to a given genotype,
and may result in parallel molecular evolution being common in
RNA viruses16.
We hypothesise that the parallel evolution of the HP genotype
from LP ancestors in AIV subtypes H5 and H7 may have a
genetic basis, and may be therefore associated with permissive or
compensatory secondary mutations occurring elsewhere in the
AIV genome. Such mutations could arise prior to, or immediately
after, the emergence of a pCS, perhaps to compensate for
mutations with antagonistic pleiotropy, or which have detri-
mental effects on protein structure or folding stability17,18. Little
is known about the genetic predisposition of AIV to acquire a
pCS (except for the role of RNA structure at the cleavage site
region itself19), nor about the role of mutations elsewhere in the
virus genome that might favour the evolution of the HP
phenotype.
The main goal of this study is to use a combination of analy-
tical methods, from evolutionary and structural biology, in order
to detect parallel mutations across the AIV genome that are
positively associated with the evolution of the HP phenotype
(hereafter termed HP-cluster associated parallel mutations, or
HAPMs). We develop, validate and implement a phylogenetic
model of binary trait evolution that tests whether genotype-to-
phenotype associations observed across multiple lineages are
statistically significant. This approach explicitly incorporates the
phylogenetic correlation among observations and thus is less
susceptible to error than standard statistical tests20. We further
investigate if the HAPMs that we identify had evolved under
positive selection, and use existing structural data and computa-
tional modelling to explore their possible effects on protein
function and/or on structure stability (Fig. 1). We identify
numerous HAPMs present in HP AIV strains belonging both to
the H5 and H7 AIV subtypes, many of which appear to be
associated with other important viral processes, including anti-
genic escape and replication efficiency. We discuss how the
mutational panel presented here can provide a starting point for
future molecular studies for the evolution of the HP phenotype.
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Fig. 1 Summary of analytical approach. A summary of our approach to
identifying HAPMs (HP-cluster associated parallel mutations) in AIV
genomes. 1. Large-scale data curation and phylogenetic analysis to detect
genotypes and phenotypes (HP lineages highlighted in red). 2.
Phylogenetically informed subsampling to reduce alignment sizes, whilst
retaining HP clusters and key mutational pathways along internal branches.
3. Detecting candidate HAPMs across multiple HP clusters (highlighted in
orange) through the reconstruction of ancestral states. 4. Selecting HAPMs
by statistical testing for genotype-to-phenotype associations using an
evolutionary-informed model (represented in the matrix by aa Y occurring
in Site X). 5. Identifying HAPMs evolving under positive selection using
different dN/dS (ω) estimation methods. 6. Inferring the possible effects of
HAPMs on protein structure stability and function, using existing structural
data and experimental literature.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-19364-x
2 NATURE COMMUNICATIONS |         (2020) 11:5511 | https://doi.org/10.1038/s41467-020-19364-x | www.nature.com/naturecommunications
Results
Large-scale phylogenetic analysis of independent HP clusters.
Large-scale phylogenetic analysis confirmed that H7NX viruses
are split into two major clades, the Eurasian and North
American lineages (Supplementary Data 1, Supplementary Fig. 1
and Fig. 2)21. H7 HP outbreaks occurred independently through
time and space and correspond to distinct lineages that, in most
cases, display a unique pCS motif (Fig. 2b)5. LP H7NX viruses
carry a consensus amino acid sequence -PEXPKGRGLF- at the HA
cleavage site, whereas a minimal consensus of -PEXPKXnK/
RnRGLF- is identified for HP viruses11. Nine H7NX HP well-
supported clusters that are spatio-temporally distinct were selected
for further analyses (Fig. 2a, b). The large-scale phylogeny of
H5NX viruses shows a basal clade of H5NX viruses circulating in
wild birds worldwide from the late 1960s to the early 2000s
(Supplementary Data 1, Supplementary Fig. 1 and Fig. 2). This
basal clade is ancestral to the established HP H5N1 lineage (named
C8 here), that diverged from A/goose/Guangdong /1/1996
(including sub-lineages 7.2 to 2.3.2.1a)22. Since its emergence in
China, this lineage has subsequently spread to Asia, Africa, Europe
and America and persists until today22. Within C8, there is a
distinct group of HP H5NX viruses, forming clade 2.3.4 and its
descendants, that circulate in both wild and domestic birds22. Eight
well-supported H5NX HP clusters that are spatio-temporally dis-
tinct were selected (Fig. 2c, d). Most HP clusters displayed a unique
pCS sequence, except for C8, reflecting the ongoing evolution of
this unusually long-lived lineage22 (Fig. 2d).
Although reassortment is common among AIVs23, our results
do not provide evidence for reassortment within HP lineages
themselves, as HP clusters were observed to be monophyletic and
well supported in all genome segment trees (Supplementary
Figs. 2–4). There are two exceptions to this; the H7N9 cluster C1
that splits into two clusters (C1.1. and C1.2) in all internal
genome segment trees, and H5N1 cluster C8, which splits into
two clusters (C8.1. and C8.2) in the PB2, PA and NP trees
(Supplementary Figs. 2 and 3). However, due to reassortment, the
internal gene segments of HP cluster strains may originate from
AIV subtypes other than H7NX or H5NX. Nonetheless, low
Note for C8 (not shown on map): 
This lineage corresponds to the H5NX long-lived lineage that diverged from A/goose/Guangdong /1/1996.
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Fig. 2 Historical occurrence of documented HP AIV outbreaks, and independent emergence of HP lineages. a For each H7NX HP case, the recorded date
of emergence and duration (in years), the country of emergence (highlighted in red), the virus subtype causing the outbreak, and the reported avian host
species are indicated in the map. b Phylogenetic distribution of HP lineages in the H7 subsampled phylogeny. Branches leading to LP sequences are shown
in black. HP sequences (highlighted in red) correspond to unique genotypes defined by a pCS (shown next to the phylogeny), as they form independent
well-supported lineages (as defined in ‘Methods’, indicated by C1-C9, showing posterior probability and bootstrap support values >80 or 0.8 for nodes of
interest), matching the historical occurrence of the documented HP outbreaks. c Historical occurrence of documented H5NX HP outbreaks, following the
description used for panel (a). Data for C8 is not included, as since 1996, this lineage circulates worldwide. d Phylogenetic distribution of HP lineages in the
H5 subsampled phylogeny, following the description used for panel (b). Distinct, well-supported HP clusters are highlighted in red (C1-C8). The H5NX HP
viruses within cluster C8 (clade 2.3.4 and descending lineages) are highlighted in blue. Maps for the global distribution for the H5NX and H7NX HPAIV
were generated with the tool http://gamapserver.who.int/mapLibrary/default.aspx under the CC BY-NC-SA 3.0 IGO license with preprint permission
authorisation 362444 for WHO copyrighted material. Maps were further edited using Adobe Illustrator for the purposes needed.
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phylogenetic support in the internal segment trees reflects that
the origin of these segments cannot, in many instances, be
determined (Supplementary Figs. 1 and 2). We conclude that
most HP clusters for both H5NX and H7NX are short-lived,
emerging and dying out within a time-span too short to allow for
reassortment. An exception to this is H5NX C8 (i.e. cluster
2.3.4.4), which is a long-established HP lineage in domestic bird
populations and is known to have reassorted with other
AIVs22,24, as is consequently split within internal genome
segment trees.
Identifying HAPMs significantly associated with the HP phe-
notype. The number of amino acid sites that were polymorphic
(i.e. present at >1% frequency) varied among virus subtypes and
genome segments. For H7NX viruses, the number of polymorphic
sites per segment ranged from 21 (for M1) to 125 (for HA).
Maximum likelihood ancestral state reconstructions revealed 16
convergent genetic changes (i.e. candidate HAPMs) that were
present in two or more H7NX HP clusters (Supplementary
Data 2). For H5NX viruses, between 12 (for M1) and 141 (for
HA) polymorphic sites were detected per segment. We identified
39 convergent genetic changes (candidate HAPMs) that were
present in two or more H5NX HP lineages (Supplementary
Data 2). Of these, 17 occurred within sub-lineages of cluster C8,
and were not considered further.
To identify those HAPMs significantly associated with the HP
phenotype, we developed a phylogenetic model to test the null
hypothesis of no association between mutations at each position
and the HP phenotype (Supplementary Text 5). For H7NX
viruses, we found a strong association with the HP phenotype for
7 out of 16 mutations (see λ and significance in Table 1). For
H5NX viruses, a strong association with the HP phenotype was
supported for 10 out of 22 mutations (Table 1). For some H7NX
HP clusters, we identified a 20-residue deletion within the stalk
region of the N1, N3 and N9 strains (Supplementary Fig. 4,
Supplementary Data 2). However, this deletion was not scored as
an HAPM under our model. The frequency of stalk-deletion
mutations is known to fluctuate in time and space among both LP
and HP viruses25. Although some deletions have been experi-
mentally linked to increased virulence, their occurrence is likely
associated with host switching (from wild bird to gallinaceous
hosts), rather than with the emergence of the HP phenotype25,26.
Our ancestral state reconstructions show that HAPMs occur on
the ancestral nodes of HP clusters, or on branches within HP
clusters, but are not observed on LP branches that are ancestral to
HP clusters (Supplementary Data 2, Supplementary Figs. 5–8 and
Fig. 3). Therefore, given the phylogenetic resolution of our
datasets, it is not possible to determine if HAPMs appear shortly
before, during, or after the emergence of the HP phenotype. This
limits our ability to determine if they are permissive or
compensatory changes. The likely cause of this is a sampling
bias towards HP isolates collected during outbreaks, resulting in
an under-representation of the immediate LP ancestors of HP
clusters. This conclusion is supported by the long branches
leading to the emergence of some HP clusters, e.g. C6 H7NX and
C3 H5NX (Fig. 2, Supplementary Figs. 2 and 3). In general, the
ML and the MCC phylogenies were consistent.
Figure 3 illustrates the evolutionary dynamics of four selected
HAPMs significantly associated with the HP phenotype. We
observed high posterior probability values for ancestral amino
acids at nodes preceding the emergence of HP clusters. By way of
illustration, extensive parallel evolution is exhibited by mutation
143T in H7, which occurs in five HP clusters (Fig. 3a). Evolution
at site 154 in H5 occurs within three HP clusters and exhibits a
more complex, step-wise evolutionary process, from N to I/L to
Q, reflecting a transition from LP to HP (Fig. 3b). N is present
only in LP viruses, I/L occurs in HP viruses circulating prior to
and during the early expansion of C8, and Q is only present in
more recent HP viruses from C8. Examples of HAPMs occurring
within internal genome segments are site 355 in H7NX PB2 and
site 627 in H5NX PB2. Mutation 355K is present in HP clusters
C5 and C6, but not in lineages representing the LP background
(Fig. 3c). A similar pattern is seen for mutation 627K in the PB2
Table 1 HAPMs significantly associated with the HP phenotype of H5 and H7 virus subtypes.
HAPM Segment HP clusters Num. HP clusters H7 numbering Referencesa λ [95% CI] P value Significanceb
H7NX
R355Kc PB2 C5 and C6 2 58 11.0 [6.8−16.7] <0.0001 **
A143Tc HA C2, C5, C6, C7 and C8 5 125 38, 68–70 7.1 [3.3, 13.2] <0.0001 **
V480I PB2 C5 and C6 2 8.5 [5.2−13.2] <0.0001 **
M/L274I HA C4 and C8 2 256 6.2 [3.1, 11.5] 0.0024 **
S152L PB1 C6 and C9 2 5.4 [3.4−8.2] 0.0045 **
V438I HA C3 and C8 2 423 4.6 [2.4, 8.3] 0.0093 *
D384N HA C6 and C8 2 369 5.1 [2.6, 9.5] 0.018 *
H5NX
V113I PB1 C2, C4 and C8 3 2.6 [1.6−4.5] 0.0022 **
K379R HA C1 and C8 2 363 14.8 [7.4, 27.5] 0.0040 **
M242I HA C1 and C8 2 226 73 7.4 [3.7, 13.7] 0.0048 **
S145L/deld HA C5 and C8 2 129 38, 63 See footnote 0.0059 *
A674T PB2 C2 and C6 2 66 5.8 [3.6−9.1] 0.0060 *
N154I/L/Qc, e HA C6, C7 and C8 3 138 60 See footnote 0.022 *
F127Lc HA C3, C7 and C8 3 111 60 6.5 [3.3, 12] 0.025 *
I167T HA C6 and C8 2 151 62 5.8 [3.0, 10.4] 0.026 *
T204I HA C2 and C8 2 188 2.7 [1.4, 4.7] 0.028 *
E627K PB2 C1 and C8 2 2.9 [1.8−4.6] 0.038 *
aWhere such HAPMs had been previously mentioned.
b‘*’ indicates a p value < 0.05, whilst ‘**’ indicates a p value < 0.01.
cScored as positively selected site under different methods (see Supplementary Table 1 in the Supplementary Information).
dIndividual lambda values for each site are as follows: for 145 L 77.5 [69.5, 100.0] with a p value of 0.00, and for 145del 7.0 [0.5, 14.7] with a p value of 0.04.
eIndividual lambda values for each site are as follows: for 154I 1.7 [1.0, 2.7], for 154 L 3.2 [1.9, 5.2] and for 154Q: 3.4 [2.0, 5.8], all with a p value of 0.00.
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of H5NX viruses, present in C1 and C8, but now fixed among LP
virus populations (Fig. 3d). For details on sampling date, location,
and host species, see Supplementary Figs. 5–8.
We further investigated if HAPMs that are significantly
associated with the HP phenotype are also present in HP
sequences that were not used in the subsampled alignments
(Supplementary Data 3). We found that, in addition to the
selected HP, mutation 154L in H5 was also fixed in two
independent HP H5N1 outbreaks in Vietnam from 2008 to
2013 27, and in HP H5N2 viruses in China circulating from 2009
to 2015 28 (Supplementary Data 3). We also observed that
mutation 143T is present in H7N6 viruses isolated from an
outbreak in Aichi prefecture, Japan, in 2009 29 (Fig. 3a; Supple-
mentary Data 1 and 3). Although this was not an HP outbreak,
these viruses contained an additional arginine residue within the
pCS (-PKGR to -PKRR), which triggered concerns about whether
this lineage might evolve the HP phenotype. Fortunately, this
lineage was successfully eradicated before any HP phenotype
strains were observed29. The presence of HAPMs in these HP
sequences constitute an independent test of our statistical
approach.
HAPMs associated with diversifying positive selection. As
parallel evolution is often a consequence of positive selection,14
we investigated whether some HAPMs were inferred as being
positively selected sites (PSS; see ‘Methods’, subsection ‘Testing
for diversifying positive selection’). Molecular evolutionary theory
posits that most mutations within a coding sequence are expected
to be deleterious, and are thus eliminated by purifying selection30.
A smaller proportion of mutations are expected to be selectively
neutral or nearly neutral, or beneficial, in which case they may be
retained by directional or diversifying positive selection30. As
expected for AIVs, and for RNA viruses in general16, dN/dS (ω)
estimates for whole genome segments were <1 in all cases and the
overall proportion of PSS detected was low (Supplementary
Table 1 and Supplementary Data 4).
For all alignments, and under all methods, most codons
exhibited ω≪ 1 (strong purifying selection) or ω < 1 (weaker
purifying selection or nearly neutral change). HA was the
segment with the highest proportion of sites with ω > 1, but even
in HA most codons had ω ≤ 1 (86% of codons for H5 and 92% of
codons for H7),31. FUBAR revealed 458 codons evolving under
episodic negative/purifying selection in H5, compared to five sites
evolving under episodic positive/diversifying selection (posterior
probability of ≥0.9). For H7, 417 sites were inferred to evolve
under episodic negative/purifying selection, whilst zero sites were
found to be under episodic positive/diversifying selection (poster-
ior probability of ≥0.9).
Analyses under branch-site models showed evidence for
diversifying positive selection acting upon some HP clusters
(H7NX clusters C4 and C7, and H5NX clusters C1, C2 and C4;
Supplementary Table 1). Analyses under site models revealed for
the H7NX subtype, 2/7 of the HAPMs significantly associated
with the HP phenotype were identified as PSS. For the H5NX
subtype, 2/10 of HAPMs were identified as PSS (see Supplemen-
tary Table 1 for details). At first impression, this suggests that
most HAPMs significantly associated with the HP phenotype are
not a consequence of positive selection14,17. However, some
HAPMs may be selectively neutral in the absence of a pCS (LP
phenotype), but offer a positive effect associated with a pCS (HP
phenotype). Thus, they may not be inferred as a PSS using dN/dS
methods, as these are rather conservative in detecting sites under
positive selection in some circumstances32. For example, muta-
tion E627K in PB2, which was not inferred to be a PSS, is known
to have a positive effect on the adaptation of AIV to mammalian
hosts and increases replication efficacy33. The role of selection on
whole HP lineages is less clear: for example, experiments in
turkey populations suggest that the HP and LP phenotypes of
H7N1 viruses have indistinguishable transmission rates and basic
reproductive numbers (R0)34.
Inferring possible effects of HAPMs on protein structure and
function. Despite experimental validations, we investigated
HAPMS in the context of existing virus protein structures and the
experimental literature on the potential functional significance of



























































Fig. 3 Reconstruction of amino acid evolution at selected HAPMs.Maximum clade credibility (MCC) trees showing the reconstruction of ancestral states
for four illustrative HAPMs (a−d). Branches are coloured according to the inferred ancestral amino acid states (tip states not shown). Nodes representing
the immediate LP ancestors and nodes from which the HP clusters directly descend are shown with circles. The posterior probabilities for a given amino
acid state occurring at the specified node are indicated. The HP sequences (HP clusters) are highlighted in orange, whilst the immediate ancestral LP
sequences are highlighted in grey. For details on sampling date, location, and host species, see Supplementary Figs. 5–8.
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values35, and thus predicted to represent fairly stabilising/neutral
changes to protein structure and folding (Figs. 4 and 5). For the
HA of the H7NX subtype (Fig. 4a), A143T in HA is a non-
conservative amino acid change located in a solvent-accessible
region within the 130-loop proximal to the receptor surface. This
is within antigenic pocket A contributing to the electrostatic
environment needed for ligand binding. Five antigenic regions
(A−E) have been identified within antigenic pocket A for the A
(H1N1) pdm09 virus, with site 143 located within five residues N-
terminal to antigenic site A36. Although it has no direct inter-
action with glycans37, mutation A143T induces glycosylation of
residue 141 by adding an N-linked glycosylation motif. This N-
linked residue produces steric masking of the antigenic site and
may affect HA folding and stability38. Other HAMPs with
potential functional relevance for the H7NX subtype include M/
L271I in HA, located within the receptor binding subdomain39,40,
and R355K in PB2 (Fig. 4b), which is a conservative amino acid
change within a solvent-exposed loop of the electrostatic surface
of the cap binding domain. This site is in direct contact with first
phosphate after the cap41 and correlates with high pathogenicity
of AIVs in mouse models42.
For the HA of the H5NX subtype (Fig. 5a), HAMPs of
potential functional relevance include mutation F127L in HA,
which is a conservative amino acid change within the globular
head of HA1 close to antigenic site 3 43. Similarly, mutation
N154I/L/Q is a non-conservative change within antigenic site 2
and involves the loss of the asparagine-linked glycosylation site44.
Both of these correspond to variable sites related to escape
mutants43. However, they are not crucial for the protective
efficacy of H5 vaccines, suggesting that the loss of the saccharide
linkage may have little impact on antigenic variation40,44. I167T
in HA is located in the surface-exposed region, and has been
related to increased infectivity in the human lower respiratory
tract in HP H5N1 viruses from Egypt45. S145L in HA is also
located in the surface-exposed region and has been linked to
increased virulence in poultry46. This site also undergoes
occasional deletion (observed in ~10% of sequences) and it has
been argued to be critical for the antigenic evolution of long-lived
HPAIV clusters38. For the PB2 protein of H5NX viruses (Fig. 5b),
the HAPM E627K is located within the surface-exposed region in
in the ‘627 domain’, and is essential for viral RNA replication and
transcription in a cellular context47. This mutation is a well-
characterised host adaptation marker associated with enhanced
transmission in mammalian hosts48; it is rarely observed among
H5NX AIVs but appears frequently among zoonotic viruses that
caused human infections7. E627K in H5NX PB2 is predicted to be
destabilising for protein structure. However, it has been shown
that other mutations in PB2, such as A674T (also scored as a
HAPM), appear to improve the genetic stability of E627K49. Site
674 is located at the interface of the polymerase complex trimer
and is predicted to increase strength of the PB2 protein
structure48,49.
Discussion
The occurrence of HAPMs in AIV genomes can be used as a
starting point for the identification of circulating variants
associated with the HP phenotype. Here we report combined
evolutionary and structural evidence to support the hypothesis
that some HAPMs are significantly associated with the HP
phenotype, and may facilitate the evolution of HP viruses. At
present we can only hypothesise on the mechanism underlying
these associations and whether they might have arisen due to
epistasis, which is thought to be common in RNA viruses due to
their limited genome sizes14. As an example of within-gene
epistasis, oseltamivir resistance in human H1N1 influenza A
viruses is conferred by mutation H274Y in N1, yet appears to
have spread only under the genetic background of two per-
missive mutations (V234M and R222Q also in N1) that enable
the virus to tolerate the detrimental effects of H274Y on protein
structure stability18. Further, PB2 mutations E627K and A674T
both scored as HAPMs and appear to epistatically interact:
A674T counteracts the structural stability induced by E627K,
whilst in vivo mouse models have shown that this mutation is a
prerequisite for the acquisition of E627K, by stabilising poly-
merase activity49. Epistatic interactions among IAV genes are
much less studied but have been proposed for genes of the IAV
polymerase complex49,50.
Previous studies have noted parallel genetic changes in inde-
pendent AIV lineages51, but these were not linked to the emer-
gence of the HP phenotype. One specific instance of parallel
genetic change associated with the transition from an LP to an
HP phenotype, giving rise to a single H7N1 HP outbreak in Italy,
has been described52–54. We provide the first systematic and
statistically rigorous screening for mutations in AIV genomes
associated with HP outbreaks. We combine phylogenetically




























Fig. 5 Functional relevance of HAPMs of H5NX viruses. Protein structure
models for the a HA (Hemagglutinin) and the b PB2 (Polymerase complex)


























Fig. 4 Functional relevance of HAPMs of H7NX viruses. Protein structure
models for the a HA (Hemagglutinin) and the b PB2/PB1 (Polymerase
complex) of the H7NX viruses. Functionally relevant HAPMs are
highlighted in red within the structural models. Only those HAMPs that are
significantly associated with the HP phenotype are indicated. Estimated
values for free energy change (ddG) are indicated for these sites. Negative
values or those close to zero can be interpreted as fairly stabilising/neutral
mutations with respect to protein structure.
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structural approaches to identify a robust set of important
mutations that could be experimentally evaluated in future
analyses.
Our statistical model for mutation−phenotype association
reformulates the test of Bhattacharya et al.20 as an evolutionary-
informed phylogenetic model that measures the strength of
association between traits. Our test uses a probabilistic approach
to account for the potential founder effects (e.g. hitchhiking
events) that arise from shared common ancestry, whilst max-
imising the statistical power to detect associations. Our model
shares similarities with some discrete trait evolution models55,56;
however, these only consider two binary traits, whereas our test
associates a binary trait (HP/LP) with multiple states (20 amino
acids). Thus, our model captures the potential dependence
between a trait and a target amino acid using a single parameter,
rather than requiring a large number of parameters to represent
each possible transition separately. This simplicity results in easily
interpretable hypothesis testing, straightforward inference using
maximum likelihood, and lower estimation variance. Available
genomes for AIV are unlikely to be randomly sampled. The LP
ancestors of many HP clusters will be under sampled, and some
HP lineages may not be sampled at all. However, due to the
phylogenetic nature of our tests, these sampling biases will lower
our statistical power to detect HAPMs, but they will not introduce
false positives. Therefore, our statistical approach is conservative
(some associations will not be detected), but robust. Further, the
simulations used to evaluate the performance of our statistical test
take account for potential sampling bias (see Supplementary
Text 5 for details). As we use a probabilistic approach, we expect
our model will gain power as sampling of HP/LP viruses
improves in the future.
Mutations that increase the fitness of the HP phenotype, for
example through permissive/compensatory effects, are expected
to be favoured in a HP genetic background, and therefore occur
repeatedly in HP lineages. Mutations that occur at nodes pre-
ceding the emergence of pCS-defined HP clusters (e.g. mutations
that are present in the immediate LP ancestors and within a HP
cluster) may represent permissive changes that facilitate the
subsequent LP−HP evolutionary transition. Alternatively, muta-
tions that occur immediately after the emergence of an HP cluster
(after a pCS has arisen) may be more likely to be compensatory
changes. Other statistical methods, such as that described in
Kryazhimskiy et al.57, use a phylogenetically informed approach
to detect positive epistasis between pairs of codons in the absence
of prior biological information57. However, it will not inform on
the timing of occurrence for sequential mutations, and thus will
not provide information on whether changes are permissive or
compensatory. A valid approach for estimating the timing of
occurrence for sequential mutations is the reconstruction of
ancestral states under a time-scaled analysis. However, we were
not able to infer with sufficient resolution the relative timing of
occurrence of most HAPMs under our time-scaled phylogenies,
in part due to the longer branches leading to some of the HP
clusters.
Some of the HAPMs identified here were independently identi-
fied in other studies, either in vitro or in silico, as being functionally
associated with the HP phenotype (Table 1)42,45,46,48–50. None-
theless, even after our study, which was designed to be statistically
conservative, it is likely that the number, biological roles, and
genomic distribution of mutations involved in HP adaptation is
underestimated. Notably, the HAPMs described here are not shared
among the H7NX and H5NX virus subtypes, yet they commonly
occur within the same genome segments (Table 1), suggesting that
the evolution of the HP phenotype may interact with other well-
studied biological processes, such as antigenic escape (determined
by the HA protein) and the replication efficiency of viral genomes,
e.g. at lower temperatures (regulated by PB2). Our findings are also
in agreement with previous works proposing that the acquisition
of a pCS may require coadaptation of the HA and other viral
proteins58.
Some of the mutations occurring close to antigenic sites may
be indirectly associated with differential patterns of immunity in
varied host populations, defined by complex factors such as
animal age and sex distributions, previous exposure to infec-
tions/vaccines, or differences in host genetic diversity59. Inter-
estingly, mathematical modelling has suggested that the sporadic
population dynamics of HP strains may be determined, at least
in part, by their linkage to one or more specific antigenic var-
iants, whose frequencies are driven by the dynamics of host
immunity, rather than by mutability24,60. Furthermore, the
emergence of the HP phenotype has been often associated with
virus adaptation from wild to domestic bird host populations51.
The strength of this association is difficult to assess in nature
given the substantial bias (in both the literature and sequence
databases) towards AIV infections and HP outbreaks in
poultry versus those in wild birds. However, using our model of
mutation−trait association (see ‘Methods’, subsection ‘Testing
for genotype-to-phenotype associations’ and Supplementary
Text 5), we found no association between any of the detected
HAMPs (or any other mutation) and the host species (domestic
versus wild bird). This suggests that the parallel mutations
identified here are not directly linked to transmission among
domestic bird populations, although high population densities
together with a limited genetic variability within the host (as
occurs in intense farming) may facilitate virus transmission. If
acquiring a pCS does indeed reduce AIV transmission fitness in
natural systems34, then it is interesting to speculate that both
intensive farming and the occurrence of secondary mutations
(HAPMs) may independently act to facilitate the spread of an
HP strain; the latter by potentially increasing the transmission
fitness of strains carrying a pCS, and the former by lowering the
threshold host density required to sustain transmission in a
population.
The results we present are derived from computational analysis
and are thus strictly predictive. Thus, further experimental vali-
dations are needed to understand how the HAPMs actually
contribute to the evolution of the HP phenotype, for example, by
stabilising protein structure, altering host−virus or virus−virus
inter-molecular interactions, or by combining additively to
increase virulence. However, such experimental validation may
take several years to complete especially if HP AIV gain-of-
function experiments will be required61. In the meantime, we
should continue to exploit fully the information revealed by
parallel molecular evolution, which represents a powerful ‘nat-
ural’ replicated experiment. This situation further highlights the
importance of systematic sampling and whole genome sequen-
cing of both HP viruses and their immediate LP ancestors, both
prior and during AIV outbreaks.
Lastly, we propose that the set of HAPMs we predict to be
associated with HP clusters selected here (or any improvement to
this set obtained in the future), may, with sufficient validation and
testing, function as an early detection system capable of high-
lighting lineages that pose a greater risk of evolving the HP
phenotype in the future, and can function as a platform for future
experimental validation. Importantly, the mutational panel
identified here could benefit AIV control even before the
mechanistic and functional actions of the mutations described are
elucidated. We suggest that circulating AIV strains in domestic
and wild bird populations that do not contain a pCS site, but
which exhibit a combination of the HAPMs identified here, are
potential targets for more focussed and targeted genomic and
epidemiological surveillance.
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Methods
We developed an analysis approach to detect parallel genetic changes associated
with the LP-to-HP evolution of AIV (summarised in Fig. 1). For convenience, we
refer to these parallel genetic changes as HAPMs (HP-cluster-associated parallel
mutations). We begin by identifying HP clusters from large-scale AIV phylogenies.
Next, we use phylogenetically informed subsampling to create smaller datasets
suitable for detailed analysis. The subsampled alignments are then analysed using
phylogenetic ancestral state reconstruction to identify convergent mutations that
might be associated with HP clusters. Associations between the mutations identi-
fied and the HP phenotype (i.e. HAPMs) are formally tested under our model. The
reduced list of HAPMs is further analysed to assess their potential functional and
selective relevance using the following criteria: (i) evidence of evolving under
positive selection, (ii) predicted to be stabilising to protein structure, and (iii)
known or predicted functional relevance derived from structural analysis and lit-
erature survey. Finally, to explore whether HAPMs might be permissive or com-
pensatory in nature, we assessed the temporal occurrence of mutation using a
molecular clock analysis. Our analysis is explained below.
Large-scale phylogenetic analysis. We downloaded from the Influenza Virus
Database all available nucleotide sequences (>80,000 sequences) corresponding to
complete AIV genome sets for the H7NX (n ≈ 3000) and H5NX (n ≈ 10,000)
subtypes, from all hosts (excluding humans) and geographical regions. Genomes
from non-avian hosts included mammals (mostly equine and swine influenza A
viruses), environmentally derived sequences (usually from avian faecal sampling)
and ND/NA (host species Not Determined/Not Available). Non-avian isolates
comprise <15% of the large-scale datasets; most of them representing sporadic
cross-species transmissions, with exception of the established equine H7NX line-
age62. Sequences were excluded if (i) they were >200nt shorter than the full coding
sequence length for each genome segment, (ii) they were identical, or (iii) they
contained >10% ambiguities. The main eight ORFs (PB2, PB1, PA, HA, NP, NA,
MS and NS) were identified and extracted. The number of H7NX ORFs were
PB2= 1856, PB1= 1787, HA= 2217, PA= 1760, NP= 1513, M1= 1682 and
NS1= 1231, and for the H5NX viruses were PB2= 3554, PB1= 3817, PA= 3421,
HA= 5650, NP= 3230, M1= 2824 and NS1= 3690. Short ORFs for PB1-F2,
PA-X, M2 and NS2 were excluded from analysis, as their short-length precluded
the molecular evolutionary analyses undertaken here. For the NA segment, all
available NA sequences were downloaded for both the H7NX and H5NX virus
subtypes (1739 sequences for H7NX and 4202 for H5NX).
Sequence datasets were aligned using MAFFT63 and preliminary large-scale
phylogenies for each genome segment were estimated using RAxML under a
general time reversible nucleotide substitution model with gamma-distributed
among-site rate variation (GTR+G). Branch support was assessed using a
bootstrap approach with 100 replicates64. We used the large-scale phylogenies to
identify all HP lineages. HP strains were identified by (i) detecting >1 basic residue
insertions within the consensus cleavage site in the HA protein alignments11 and
(ii) by confirming HP status with case reports in the literature5,11. Sequences in
other alignments were labelled HP/LP according to their status in the HA tree.
Phylogenetically informed subsampling. To render analyses computationally
feasible, we subsampled the large-scale datasets in a phylogenetically informed
manner. Firstly, clusters of HP sequences were further sub-selected under the
following criteria: (i) they are monophyletic and well supported (bootstrap value >
80) in the large-scale phylogenies of HA and other genome segments, (ii) they
contain >2 HP sequences for all genome segments, (iii) they have identifiable
immediate LP ancestors, and (iii) they emerged independently from other HP
clusters, and are thus distinct in time and space. Eight HP clusters were selected
from 10 H5NX and 15 H5N1 previously identified HP lineages11, and nine HP
clusters were selected from 24 H7NX HP lineages11. HP sequences were excluded
from our analyses if they did not form well-supported clusters, had no identifiable
immediate LP ancestors, or if sequences for all genome segments were not avail-
able. For LP sequences, subsampling was undertaken so as to retain the mutational
pathways along internal tree branches that lead from LP ancestors to HP clusters,
whilst reducing overall alignment sizes. All non-avian viruses were excluded from
all subsampled alignments, as viruses the rate and nature of molecular evolution
can vary in different hosts62.
For the H7 and H5 HA datasets we retained (i) the selected HP clusters, (ii)
their immediate LP ancestors in the tree, (iii) up to 250 randomly selected LP
reference sequences to maintain overall tree topology, and (iv) a group of ancestral
sequences for rooting purposes. In total, 313 sequences were sampled for H7 and
H5 (Supplementary Data 1). For the NA datasets, we extracted all sequences
corresponding to the NA types that are associated with the HP phenotype (for
H7NX: N1= 136 sequences, N3= 367, N7= 196 and N9= 18, and for H5NX:
N1= 2053 subsampled to 200, N2= 367, N7= 757, N3= 78, N8= 93 and N9=
223). We then merged the individual NA subtype alignments to create two global
NA alignments (for H7NX: NX= 919 and for H5NX: NX= 1146 subsampled to
600). Finally, to illustrate the genetic diversity of NA, we extracted from the large-
scale datasets all NA sequences of the isolates present in the HA subsampled
alignments (211 for H7NX and 150 for H5NX) (Supplementary Fig. 4).
AIVs of different subtypes undergo genome reassortment, especially within the
internal segments23. In order to account for this, when inferring the evolutionary
history of internal genes, we used a single phylogeny/alignment that includes all
AIV subtypes (not just viruses belonging to the H5 and H7 subtypes). In this way,
we maximise our chances of including those phylogenetic nodes that are closely
related LP ancestors to HP clusters, irrespective of AIV subtype. This procedure
aims to (i) reduce estimation error, (ii) increase accuracy of phylogeny
reconstruction, and (iii) ensure the most closely related strains to each HP lineage
are included. Consequently, for each internal segment (PB2, PB1, PA, NP M1,
NS1), we constructed a consensus sequence for each HP cluster and used blastn to
identify closely related sequences belonging all AIV subtypes other than H5NX and
H7NX, and retained the top ten hits for each search. Sequences from these hits
were added to the merged internal segment datasets (both the H5NX and H7NX
viruses, including the selected HP strains). The resulting final number of sequences
in each internal segment dataset was: PB2= 514, PB1= 541, PA= 485, NP= 503,
M1= 443 and NS1= 471.
Each dataset was re-aligned using MAFFT63 and alignments were screened
for recombination using the RDP, GENECOV and BOOTSCAN components of
the RDP3 package65. No evidence for intra-segment recombination was
detected by three or more methods under a Bonferroni-corrected p value <
0.001. The subsampled alignments were analysed using jModelTest2 to identify
well-fitting substitution models66. For each alignment, trees were estimated
using RAxML under the GTR+ G model and bootstrapped with 100
replicates64. Prior to tree estimation, HA alignments were edited to remove the
cleavage site, whilst regions with poor alignment scores were removed from the
NA alignments. Alignment sizes for the subsampled datasets are provided in
Supplementary Data 1. The varying sizes and/or missing HP clusters in some
alignments are due to the lack of complete genomes for all strains in the public
database.
Detecting candidate HAPMs co-occurring across HP clusters. To identify
candidate HAPMs within AIV genomes, all mutations (deletions, insertions and
non-synonymous variable sites) present in ≥1% of the sequences in each sub-
sampled alignment were coded as a discrete taxon trait and subjected to ancestral
state reconstruction on the subsampled RAXML trees, using the maximum like-
lihood framework implemented in the ‘ape’ R package67. The resulting recon-
structions were inspected visually to identify candidate HAPMs shared by multiple
HP clusters, indicating convergent evolution within the HP phenotype. We iden-
tified sites as candidate HAPMs if: (i) they occurred within two or more HP
clusters, (ii) they were present in >60% of the sequences within the HP clusters (i.e.
the mutation is dominant within a given HP population), and (iii) they were absent
from internal nodes that do not lead to HP lineages. Thus, candidate HAPMS may
occur on LP terminal branches across the phylogenies, but are not generally fixed
within LP lineages (Supplementary Data 2).
Testing for genotype-to-phenotype associations. We developed an evolutionary
model to statistically test for associations between binary phenotypic traits and
amino acid states in a phylogenetically informed manner. Our method serves the
same purpose as a χ2 test, but correctly incorporates the phylogenetic history of the
trait and phenotype of interest; failing to account for these phylogenetic correla-
tions can lead to erroneous false positives20,68. The model assumes that phenotypes
and amino acid states are discrete traits that change along the phylogeny. Given an
alignment, its phylogeny, and a set of binary values for each sequence, the method
tests if a specific amino acid state (candidate HAPM) is associated with the HP
phenotype. This is repeated for all amino acid states and all codons. The coupling
parameter λ is used to measure the strength of association between an amino acid
state and the phenotype state. The null hypothesis of zero association is represented
by λ= 1, and can be rejected in favour of a positive association (λ > 1) using a
likelihood ratio test (LRT). The type I and II error rates of this test were evaluated
using simulations. We applied this test to our subsampled alignments and used it to
select those mutations that are significantly associated with the HP phenotype, thus
classifying them as HAPMs. To avoid overrepresentation of the long-lived H5N1
HP viruses22, the lineage was further reduced in size by collapsing it to its most
basal sequences. A full mathematical description of the model and simulation
details are provided in Supplementary Text 5.
To explore if the detected HAPMs might represent permissive or compensatory
change, we performed a time-scaled analysis coupled with reconstruction of
ancestral states using BEAST v1.8.4 69. The temporal signal in all RAxML trees was
assessed using TempEst v.1.5, by plotting root-to-tip genetic distance against
sampling time70. As expected, this showed strong temporal signal in all trees,
suggesting a strict molecular clock is adequate for these data. From the subsampled
alignments, we estimated the posterior probability of amino acid states occurring at
tree nodes that are ancestral and immediate to HP clusters, using a discrete trait
evolution model. For this, time-scaled phylogenies were estimated using a SRD06
nucleotide substitution model, a strict molecular clock model and a Bayesian
skyline coalescent tree prior69. Partitions were generated for each site, and ancestral
states/transition rates for each mutation of interest were estimated using an
asymmetric continuous time Markov chain model71. Two MCMC runs were
computed for 100 × 106 states until convergence was reached. Maximum clade
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credibility (MCC) trees were summarised using TreeAnnotator after removing 10%
of the runs as burn-in69. Finally, we note that the presence of HAPMs in HP
viruses that were not included in the subsampled alignments could be used to test
our analysis pipeline. Therefore, to determine if selected HAPMs were present in
these HP sequences, we re-estimated the full mutational history of HAPMs by
mapping amino acid changes onto the tips of the large-scale ML phylogenies
generated in step 1 (Supplementary Data 3).
Testing for diversifying positive selection. The dN/dS ratio (also denoted ω) is
the ratio of non-synonymous substitution rate per non-synonymous site to the
synonymous substitution rate per synonymous site. It measures the selective
pressures acting on a protein coding sequence72. Site-specific models (M1a/M2a in
CODEML73 and SLAC, FEL and MEME in Datamonkey74) estimate the propor-
tion of codons that are evolving under purifying selection (ω < 1), nearly neutral/
neutral evolution (ω= 1), and diversifying positive selection (ω > 1). Branch-site
models (BSa/nBSA in CODEML and bsREL in Datamonkey) allow ω to vary along
both branches and among sites simultaneously, making it possible to identify
lineages and specific codons that have evolved under positive selection through
time73,74. In all cases, nested models are tested using the χ2 approximation to the
LRT statistic, and are further subjected to Bonferroni multiple correction for
multiple testing.
Using the site-specific models, we calculated the proportion of sites evolving in
each ω category and noted if candidate HAPMs were identified as PSS. We used the
branch-site models to detect positively selected HP clusters and associated
mutations. The subsampled alignments for each genome segment were used in the
analyses, except for the mixed NA subtype alignments (Supplementary Table 1).
Since different dN/dS-based methods differ in their statistical performance and on
the framework used for parameter estimation72,75, we undertook a conservative
approach and only report sites or HP cluster as being positively selected if they
were identified as such by at least two different methods (see Supplementary
Table 1). Finally, the output of the DEPS algorithm38 was compared with our
results, and the proportions of codons in each evolutionary class were confirmed
using the FUBAR method31. The LRT results and lists of all PSS identified using
CODEML are provided in Supplementary Data 4.
Inferring mutation effects on protein stability and function. Frequently,
mutations that may render beneficial phenotypes may also be deleterious at a
molecular level, by altering protein structural or folding stability35. We therefore
undertook structural analyses to predict, based on existing structural data and the
literature, if the HAPMs identified in previous steps could have possible impli-
cations for protein structure and stability, and/or have any potential functional
impacts (see references in Table 1). We modelled protein 3D structures from
existing structural data in the PDB database (https://pdb101.rcsb.org/), using
representative HP sequences from our datasets as queries. For H7, we used the
crystal structure of isolate A/H7N2/New York/107/2003 AIV (PDB ID 3M5G),
whilst for H5 we used the crystal structure of isolate A/Vietnam/30262III/04 AIV
(PDB ID For the PB2/PB1/PA complex), the high-resolution structure of the A/
H5N1/duck/Fujian/01/2002 virus (PDB 6QPF) was used as a template76. For all
structures, we used the I-TASSER server77 to generate models with the mutations
of interest, which were visually compared to PDB files for validation. Finally, to
predict which HAPMs might possible affect the stability of protein structures, we
used the PIPS (Phylogenetic Inference of Protein Stability) program35. This
program implements an informed Bayesian approach and estimates, for each
amino acid state, a value of free energy change (ddG) in terms of the thermo-
dynamic stability of an unfolding/refolding protein. A statistical model is used to
calculate the probability of free energy change along phylogeny branches in a
manner analogous to the computation of nucleotide substitution models, and
thereby computationally predict the occurrence of mutations altering protein
stability35. Negative ddG values are predicted to be stabilising for protein
structure. Values close to zero are predicted to have little effect or to be only
weakly stabilising, whilst positive values are predicted to destabilise protein
structure35.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All sequence data supporting the findings of this study are publicly available from
GenBank with accession numbers provided in Supplementary Data 1.
Code availability
The Julia source code for our model (compatible with Windows and Linux) is available
at: https://github.com/michaelgoldendev/trait-evolution.
Received: 14 August 2019; Accepted: 12 October 2020;
References
1. Webster, R. G., Peiris, M., Chen, H. & Guan, Y. H5N1 outbreaks and enzootic
influenza. Emerg. Infect. Dis. 12, 3–8 (2006).
2. Buxton Bridges, C. et al. Risk of influenza A (H5N1) infection among health
care workers exposed to patients with influenza A (H5N1). Hong Kong J.
Infect. Dis. 181, 344–348 (2000).
3. Du Ry van Beest Holle, M., Meijer, A., Koopmans, M. & de Jager, C. M.
Human-to-human transmission of avian influenza A/H7N7, The Netherlands,
2003. Eur. Surveill. 10, 264–268 (2005).
4. Lam, T. T. & Pybus, O. G. Genomic surveillance of avian-origin influenza A
viruses causing human disease. Genome Med. 10, 50 (2018).
5. Dhingra, M. S. et al. Geographical and historical patterns in the emergences of
novel highly pathogenic avian influenza (HPAI) H5 and H7 viruses in poultry.
Front. Vet. Sci. 5, 84 (2018).
6. Short, K. R. et al. One health, multiple challenges: the inter-species
transmission of influenza A virus. One Health 1, 1–13 (2015).
7. Hatta, M., Gao, P., Halfmann, P. & Kawaoka, Y. Molecular basis for high
virulence of Hong Kong H5N1 influenza A viruses. Science 293, 1840–1842
(2001).
8. Jackson, D., Hossain, M. J., Hickman, D., Perez, D. R. & Lamb, R. A. A new
influenza virus virulence determinant: the NS1 protein four C-terminal
residues modulate pathogenicity. Proc. Natl Acad. Sci. USA 105, 4381–4386
(2008).
9. Schmolke, M. et al. Differential contribution of PB1-F2 to the virulence of
highly pathogenic H5N1 influenza A virus in mammalian and avian species.
PLoS Pathog. 7, e1002186 (2011).
10. Horimoto, T. & Kawaoka, Y. Reverse genetics provides direct evidence for a
correlation of hemagglutinin cleavability and virulence of an avian influenza A
virus. J. Virol. 68, 3120–3128 (1994).
11. OFFLU. OIE/FAO Network of Expertise on Animal Influenza: Influenza A
Cleavage Sites Report 2018, http://www.offlu.net/fileadmin/home/en/resource-
centre/pdf/Influenza_A_Cleavage_Sites.pdf (2018).
12. Hamilton, B. S., Gludish, D. W. & Whittaker, G. R. Cleavage activation of the
human-adapted influenza virus subtypes by matriptase reveals both subtype
and strain specificities. J. Virol. 86, 10579–10586 (2012).
13. Stern, D. L. The genetic causes of convergent evolution. Nat. Rev. Genet. 14,
751–764 (2013).
14. Gutierrez, B., Escalera-Zamudio, M. & Pybus, O. G. Parallel molecular
evolution and adaptation in viruses. Curr. Opin. Virol. 34, 90–96 (2019).
15. Gutiérrez-Romero, R. & Oviedo, M. The good the bad and the ugly: The socio-
economic impact of drug cartels and their violence in Mexico. Journal of
Economic Geography 18, 1315–1338 (2018).
16. Pond, S. L., Murrell, B. & Poon, A. F. Evolution of viral genomes: interplay
between selection, recombination, and other forces. Methods Mol. Biol. 856,
239–272 (2012).
17. Frost, S. D. W., Magalis, B. R. & Kosakovsky Pond, S. L. Neutral theory and
rapidly evolving viral pathogens. Mol. Biol. Evol. 35, 1348–1354 (2018).
18. Bloom, J. D., Gong, L. I. & Baltimore, D. Permissive secondary mutations
enable the evolution of influenza oseltamivir resistance. Science 328,
1272–1275 (2010).
19. Nao, N. et al. Genetic predisposition to acquire a polybasic cleavage site for
highly pathogenic avian influenza virus hemagglutinin. MBio https://doi.org/
10.1128/mBio.02298-16 (2017).
20. Bhattacharya, T. et al. Founder effects in the assessment of HIV
polymorphisms and HLA allele associations. Science 315, 1583–1586 (2007).
21. Xu, Y. et al. Limited antigenic diversity in contemporary H7 avian-origin
influenza A viruses from North America. Sci. Rep. 6, 20688 (2016).
22. Smith, G. J., Donis, R. O., World Health Organization/World Organisation for
Animal, H. F. & Agriculture Organization, H. E. W. G. Nomenclature updates
resulting from the evolution of avian influenza A(H5) virus clades 2.1.3.2a,
2.2.1, and 2.3.4 during 2013-2014. Influenza Other Respir. Viruses 9, 271–276
(2015).
23. Lu, L., Lycett, S. J. & Leigh Brown, A. J. Reassortment patterns of avian
influenza virus internal segments among different subtypes. BMC Evol. Biol.
14, 16 (2014).
24. Thompson, C. P. et al. A naturally protective epitope of limited variability as
an influenza vaccine target. Nat. Commun. 9, 3859 (2018).
25. Li, J., Zu Dohna, H., Cardona, C. J., Miller, J. & Carpenter, T. E. Emergence
and genetic variation of neuraminidase stalk deletions in avian influenza
viruses. PLoS ONE 6, e14722 (2011).
26. McAuley, J. L., Gilbertson, B. P., Trifkovic, S., Brown, L. E. & McKimm-
Breschkin, J. L. Influenza virus neuraminidase structure and functions. Front.
Microbiol. 10, 39 (2019).
27. Nguyen, T. et al. Characterization of a highly pathogenic avian influenza
H5N1 virus sublineage in poultry seized at ports of entry into Vietnam.
Virology 387, 250–256 (2009).
28. Zhao, G. et al. Novel reassortant highly pathogenic H5N2 avian influenza
viruses in poultry in China. PLoS ONE 7, e46183 (2012).
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-19364-x ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:5511 | https://doi.org/10.1038/s41467-020-19364-x | www.nature.com/naturecommunications 9
29. Uchida, Y. et al. Genetic characterization and susceptibility on poultry and
mammal of H7N6 subtype avian influenza virus isolated in Japan in 2009. Vet.
Microbiol. 147, 1–10 (2011).
30. Loewe, L. & Hill, W. G. The population genetics of mutations: good, bad and
indifferent. Philos. Trans. Roy. Soc. B 365, 1153–1167 (2010).
31. Murrell, B. et al. FUBAR: a fast, unconstrained bayesian approximation for
inferring selection. Mol. Biol. Evol. 30, 1196–1205 (2013).
32. Anisimova, M. & Kosiol, C. Investigating protein-coding sequence evolution
with probabilistic codon substitution models. Mol. Biol. Evol. 26, 255–271
(2009).
33. Linster, M. et al. Identification, characterization, and natural selection of
mutations driving airborne transmission of A/H5N1 virus. Cell 157, 329–339
(2014).
34. Saenz, R. A. et al. Quantifying transmission of highly pathogenic and low
pathogenicity H7N1 avian influenza in turkeys. PLoS ONE 7, e45059 (2012).
35. Bloom, J. D. & Glassman, M. J. Inferring stabilizing mutations from protein
phylogenies: application to influenza hemagglutinin. PLoS Comput Biol. 5,
e1000349 (2009).
36. Jimenez-Alberto, A., Alvarado-Facundo, E., Ribas-Aparicio, R. M. & Castelan-
Vega, J. A. Analysis of adaptation mutants in the hemagglutinin of the
influenza A(H1N1)pdm09 virus. PLoS ONE 8, e70005 (2013).
37. Yang, H., Chen, L. M., Carney, P. J., Donis, R. O. & Stevens, J. Structures of
receptor complexes of a North American H7N2 influenza hemagglutinin
with a loop deletion in the receptor binding site. PLoS Pathog. 6, e1001081
(2010).
38. Kosakovsky Pond, S. L., Poon, A. F., Leigh Brown, A. J. & Frost, S. D. A
maximum likelihood method for detecting directional evolution in protein
sequences and its application to influenza A virus. Mol. Biol. Evol. 25,
1809–1824 (2008).
39. Lu., J. et al. Molecular evolution, diversity and adaptation of H7N9 influenza
A viruses in China. Emerg. Infect. Dis. https://doi.org/10.3201/eid2410.171063
(2018).
40. Ha, Y., Stevens, D. J., Skehel, J. J. & Wiley, D. C. H5 avian and H9 swine
influenza virus haemagglutinin structures: possible origin of influenza
subtypes. EMBO J. 21, 865–875 (2002).
41. Guilligay, D. et al. The structural basis for cap binding by influenza virus
polymerase subunit PB2. Nat. Struct. Mol. Biol. 15, 500–506 (2008).
42. Katz, J. M. et al. Molecular correlates of influenza A H5N1 virus pathogenesis
in mice. J. Virol. 74, 10807–10810 (2000).
43. Stevens, J. et al. Structure and receptor specificity of the hemagglutinin from
an H5N1 influenza virus. Science 312, 404–410 (2006).
44. Hoffmann, E., Lipatov, A. S., Webby, R. J., Govorkova, E. A. & Webster, R. G.
Role of specific hemagglutinin amino acids in the immunogenicity and
protection of H5N1 influenza virus vaccines. Proc. Natl Acad. Sci. USA 102,
12915–12920 (2005).
45. Saleh, M. M., Selim, A., Shahera, A. A., El -Shahidy, M. S. & El-Trabilli, M. M.
Molecular characterization of recently isolated highly pathogenic avian
influenza virus (H5N1) in Egypt. Nat. Sci. 15, 103–109 (2017).
46. Perdue, M. L. & Suarez, D. L. Structural features of the avian influenza virus
hemagglutinin that influence virulence. Vet. Microbiol. 74, 77–86 (2000).
47. Nilsson, B. E., Te Velthuis, A. J. & Fodor, E. Role of the PB2 627 domain in
influenza A virus polymerase function. J. Virol. https://doi.org/10.1128/
JVI.02467-16 (2017).
48. Steel, J., Lowen, A. C., Mubareka, S. & Palese, P. Transmission of influenza
virus in a mammalian host is increased by PB2 amino acids 627 K or 627E/
701 N. PLoS Pathog. 5, e1000252 (2009).
49. Long, J. S. et al. The effect of the PB2 mutation 627 K on highly pathogenic
H5N1 avian influenza virus is dependent on the virus lineage. J. Virol. 87,
9983–9996 (2013).
50. Lee, C. Y. et al. Prerequisites for the acquisition of mammalian pathogenicity
by influenza A virus with a prototypic avian PB2 gene. Sci. Rep. 7, 10205
(2017).
51. Lebarbenchon, C. & Stallknecht, D. E. Host shifts and molecular evolution of
H7 avian influenza virus hemagglutinin. Virol. J. 8, 328 (2011).
52. Monne, I. et al. Emergence of a highly pathogenic avian influenza virus from a
low-pathogenic progenitor. J. Virol. 88, 4375–4388 (2014).
53. Fusaro, A. et al. Evolutionary trajectories of two distinct avian influenza
epidemics: Parallelisms and divergences. Infect. Genet. Evol. 34, 457–466
(2015).
54. Banks, J. et al. Changes in the haemagglutinin and the neuraminidase genes
prior to the emergence of highly pathogenic H7N1 avian influenza viruses in
Italy. Arch. Virol. 146, 963–973 (2001).
55. Pagel, M. Detecting correlated evolution on phylogenies—a general-method
for the comparative-analysis of discrete characters. Proc. R. Soc. B—Biol. Sci.
255, 37–45 (1994).
56. Pagel, M. & Meade, A. Bayesian analysis of correlated evolution of discrete
characters by reversible-jump Markov chain Monte Carlo. Am. Nat. 167,
808–825 (2006).
57. Kryazhimskiy, S., Dushoff, J., Bazykin, G. A. & Plotkin, J. B. Prevalence of
epistasis in the evolution of influenza A surface proteins. PLoS Genet. https://
doi.org/10.1371/journal.pgen.1001301 (2011).
58. Veits, J. et al. Avian influenza virus hemagglutinins H2, H4, H8, and
H14 support a highly pathogenic phenotype. Proc. Natl Acad. Sci. USA 109,
2579–2584 (2012).
59. Hill, S. C. et al. Antibody responses to avian influenza viruses in wild birds
broaden with age. Proc. Biol. Sci. https://doi.org/10.1098/rspb.2016.2159 (2016).
60. Wikramaratna, P. S., Pybus, O. G. & Gupta, S. Contact between bird species of
different lifespans can promote the emergence of highly pathogenic avian
influenza strains. Proc. Natl Acad. Sci. USA 111, 10767–10772 (2014).
61. Casadevall, A. & Imperiale, M. J. Risks and benefits of gain-of-function
experiments with pathogens of pandemic potential, such as influenza virus: a
call for a science-based discussion. MBio 5, e01730–01714 (2014).
62. Worobey, M., Han, G. Z. & Rambaut, A. A synchronized global sweep of the
internal genes of modern avian influenza virus. Nature 508, 254–257 (2014).
63. Katoh, K., Misawa, K., Kuma, K. & Miyata, T. MAFFT: a novel method for
rapid multiple sequence alignment based on fast Fourier transform. Nucleic
Acids Res. 30, 3059–3066 (2002).
64. Stamatakis, A. RAxML version 8: a tool for phylogenetic analysis and post-
analysis of large phylogenies. Bioinformatics 30, 1312–1313 (2014).
65. Martin, D. P. et al. RDP3: a flexible and fast computer program for analyzing
recombination. Bioinformatics 26, 2462–2463 (2010).
66. Darriba, D., Taboada, G. L., Doallo, R. & Posada, D. jModelTest 2: more
models, new heuristics and parallel computing. Nat. Methods 9, 772 (2012).
67. Paradis, E. & Schliep, K. ape 5.0: an environment for modern phylogenetics
and evolutionary analyses in R. Bioinformatics https://doi.org/10.1093/
bioinformatics/bty633 (2018).
68. Harvey, P. H. & Pagel, M. D. The Comparative Method in Evolutionary Biology
(Oxford University Press, 1991).
69. Drummond, A. J., Suchard, M. A., Xie, D. & Rambaut, A. Bayesian phylogenetics
with BEAUti and the BEAST 1.7. Mol. Biol. Evol. 29, 1969–1973 (2012).
70. Rambaut, A., Lam, T. T., Max Carvalho, L. & Pybus, O. G. Exploring the
temporal structure of heterochronous sequences using TempEst (formerly
Path-O-Gen). Virus Evol. 2, vew007 (2016).
71. Ferreira, M. A. R. & Suchard, M. A. Bayesian analysis of elapsed times in
continuous-time Markov chains. Can. J. Stat. 36, 355–368 (2008).
72. Kosakovsky Pond, S. L. & Frost, S. D. Not so different after all: a comparison
of methods for detecting amino acid sites under selection. Mol. Biol. Evol. 22,
1208–1222 (2005).
73. Yang, Z. PAML 4: phylogenetic analysis by maximum likelihood. Mol. Biol.
Evol. 24, 1586–1591 (2007).
74. Delport, W., Poon, A. F., Frost, S. D. & Kosakovsky Pond, S. L. Datamonkey
2010: a suite of phylogenetic analysis tools for evolutionary biology.
Bioinformatics 26, 2455–2457 (2010).
75. Anisimova, M., Bielawski, J. P. & Yang, Z. Accuracy and power of Bayes
prediction of amino acid sites under positive selection. Mol. Biol. Evol. 19,
950–958 (2002).
76. Fan, H. et al. Structures of influenza A virus RNA polymerase offer insight
into viral genome replication. Nature 573, 287–290 (2019).
77. Yang, J. et al. The I-TASSER Suite: protein structure and function prediction.
Nat. Methods 12, 7–8 (2015).
Acknowledgements
M.E.-Z was supported by an EMBO Long Term Fellowship (ALTF376-2017) during this
work, and is currently supported by Leverhulme Trust ECR Fellowship (ECF-2019-542).
M.G., J.T. and O.G.P. are supported by the EU’s Seventh Framework Programme (FP7/
2007-2013)/European Research Council (614725-PATHPHYLODYN). B.G. is supported
by the 2017 Universities of Academic Excellence Scholarship Program of the Secretariat
for Higher Education, Science, Technology and Innovation of the Republic of Ecuador
(ARSEQ-BEC-003163-2017) and by Universidad San Francisco de Quito. J.R.K. and L.C.
are supported by the Wellcome Investigator award (200835/Z/16/Z). The Wellcome
Centre for Human Genetics is supported by grant 203141/Z/16/Z. T.A.B. is supported by
the Medical Research Council (MR/L009528/1). We thank Dr. Sergey Kryazhimskiy for
his constructive comments on our model, and Dr. Sergei Kosakovsky Pond for his
valuable advice on the methodology for detection of positive selection.
Author contributions
M.E.-Z. and O.G.P. designed the research. M.E.-Z. performed the research. M.E.-Z. and
O.G.P. analysed data. M.G. developed the statistical model and analysed data. B.G. and J.T.
analysed genomic data. J.R.K. and L.C. analysed structural data. T.A.B. supervised structural
data analysis. M.E.Z. wrote the manuscript, with comments from all authors.
Competing interests
The authors declare no competing interests.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-19364-x
10 NATURE COMMUNICATIONS |         (2020) 11:5511 | https://doi.org/10.1038/s41467-020-19364-x | www.nature.com/naturecommunications
Additional information
Supplementary information is available for this paper at https://doi.org/10.1038/s41467-
020-19364-x.
Correspondence and requests for materials should be addressed to M.E.-Z. or O.G.P.
Peer review information Nature Communications thanks the anonymous reviewers for
their contribution to the peer review of this work. Peer reviewer reports are available.
Reprints and permission information is available at http://www.nature.com/reprints
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2020
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-19364-x ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:5511 | https://doi.org/10.1038/s41467-020-19364-x | www.nature.com/naturecommunications 11
